Prognostic Value of Leukocytosis and Lymphopenia for Coronavirus Disease Severity
- PMID: 32384045
- PMCID: PMC7392413
- DOI: 10.3201/eid2608.201160
Prognostic Value of Leukocytosis and Lymphopenia for Coronavirus Disease Severity
Abstract
To evaluate lymphopenia as a marker for coronavirus disease severity, we conducted a meta-analysis of 10 studies. Severe illness was associated with lower lymphocyte and higher leukocyte counts. Using these markers for early identification of patients with severe disease may help healthcare providers prioritize the need to obtain therapy.
Keywords: 2019 novel coronavirus disease; COVID-19; SARS-CoV-2; coronavirus disease; leukocytosis; lymphopenia; meta-analysis; respiratory infections; severe acute respiratory syndrome coronavirus 2; viruses; zoonoses.
References
-
- Coronavirus COVID-19 Global Cases by the Center for Systems Science and Engineering (CSSE) at Johns Hopkins University [cited 2020 Mar 29]. https://gisanddata.maps.arcgis.com/apps/opsdashboard/index.html#/bda7594...
-
- Conti P, Ronconi G, Caraffa A, Gallenga CE, Ross R, Frydas I, et al. Induction of pro-inflammatory cytokines (IL-1 and IL-6) and lung inflammation by Coronavirus-19 (COVI-19 or SARS-CoV-2): anti-inflammatory strategies. J Biol Regul Homeost Agents. 2020;34:1. - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Miscellaneous
